Replimune Group, Inc.(REPL) announced the pricing of its public offering of 6.923 million common shares at $13.00 per share. The offering is expected to close on November 27, 2024.
Replimune announced the pricing of public offering of pre-funded warrants to purchase 3.846 million common shares at a purchase price of $12.9999 per pre-funded warrant, which equals public offering price per share of common stock less the $0.0001 per share exercise price of each pre-funded warrant.
In addition, Replimune has granted underwriter a 30-day option to purchase up to an additional 1.615 common shares.
The company expects offering gross proceeds to be about $140 million, before expenses.
Leerink Partners is acting as sole bookrunning manager for the offering.
For comments and feedback contact: editorial@rttnews.com
Business News
April 17, 2026 15:29 ET The ongoing conflict in the Middle East continues to raise concerns for policymakers who worry about the impact of the supply shock and high energy prices on the real economy. Producer price data and various survey results on the housing market were the main news from the U.S. this week. In Europe, industrial production data for the euro area gained attention. GDP figures out of China and the policy move by the Singapore central bank were in focus in Asia.